Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven ...

Xaira Therapeutics today announced the appointment of Dr. Paulo Fontoura and Dr. Hetu Kamisetty to its C-suite. Fontoura will serve as chief medical officer effective early 2025, and Kamisetty will ...

Scientists are uncovering new insights into the mechanisms driving neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). These fatal diseases ...

National Institute of Health (NIH) scientists have made a significant breakthrough in understanding how "bad" cholesterol, known as low-density ...